Erland Erdmann

Q: What Schools Are Affiliated With Erland Erdmann

Erland Erdmann is affiliated with the following schools: University of Hull, University of Cologne, Ludwig Maximilian University of Munich

Erland Erdmann's AcademicInfluence.com Rankings

Erland Erdmann

Computer Science

#3971

World Rank

#4175

Historical Rank

Machine Learning

#642

World Rank

#652

Historical Rank

Artificial Intelligence

#840

World Rank

#856

Historical Rank

Database

#1211

World Rank

#1275

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Erland Erdmann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Erland Erdmann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of cardiac resynchronization on morbidity and mortality in heart failure. (2005) (6052)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial (2005) (3960)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (2006) (1767)
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. (1993) (883)
Intracellular Calcium Handling in Isolated Ventricular Myocytes From Patients With Terminal Heart Failure (1992) (859)
Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. (2015) (780)
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. (1993) (777)
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. (2006) (643)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison (2006) (484)
Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. (1995) (423)
The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study. (2007) (392)
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. (2012) (378)
An atypical variant of Fabry's disease with manifestations confined to the myocardium. (1991) (371)
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. (1990) (338)
Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite Sequence: Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III (2005) (328)
The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points (2001) (310)
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. (1998) (307)
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. (1994) (301)
Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease (2007) (263)
Reduced Ca2+-Sensitivity of SERCA 2a in Failing Human Myocardium due to Reduced Serin-16 Phospholamban Phoshorylation (1999) (263)
Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. (1993) (262)
Ischemic Preconditioning for Prevention of Contrast Medium–Induced Nephropathy: Randomized Pilot RenPro Trial (Renal Protection Trial) (2012) (257)
The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. (2004) (235)
The failing human heart is unable to use the Frank-Starling mechanism. (1994) (231)
Evidence for reduction of norepinephrine uptake sites in the failing human heart. (1995) (230)
Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure (2006) (216)
Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. (1988) (202)
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. (2012) (189)
Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. (1998) (185)
Reduced Sodium Pump α1, α3, and β1-Isoform Protein Levels and Na+,K+-ATPase Activity but Unchanged Na+-Ca2+ Exchanger Protein Levels in Human Heart Failure (1999) (182)
Ouabain-receptor interactions in (Na + +K + )-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants. (1973) (179)
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. (2007) (176)
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. (2003) (171)
Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. (1999) (168)
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey (2005) (163)
Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. (2016) (163)
Use of NT‐proBNP in routine testing and comparison to BNP (2004) (163)
Local versus general anesthesia for transfemoral aortic valve implantation (2011) (159)
Altered Expression of, ‐Adrenergic Receptor Kinase and 1‐Adrenergic Receptors in the Failing Human Heart (1993) (158)
Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults (2008) (157)
The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. (1996) (155)
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. (2006) (153)
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. (1996) (149)
Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. (1991) (137)
Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. (1991) (136)
Effect of Inotropic Stimulation on the Negative Force‐Frequency Relationship in the Failing Human Heart (1993) (134)
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. (1996) (134)
cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. (1994) (133)
Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. (1980) (131)
Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. (1992) (129)
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. (2008) (128)
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. (2013) (128)
Long‐term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization‐Heart Failure (CARE‐HF) trial (2012) (126)
Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. (1997) (122)
Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10). (2008) (120)
Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the “French paradox” (2002) (116)
α‐Adrenoceptors and α ‐Adrenoceptor‐Mediated Positive Inotropic Effects in Failing Human Myocardium (1988) (115)
Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure (2013) (113)
Beta-blocking agents in heart failure. Should they be used and how? (1996) (112)
Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. (1996) (110)
Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes (2012) (104)
Desensitization of adenylate cyclase and increase of Gi alpha in cardiac hypertrophy due to acquired hypertension. (1992) (103)
Subsensitivity of the Failing Human Heart to Isoprenaline and Milrinoneo is Related to β‐Adrenoceptor Downregulation (1988) (97)
Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure. (1995) (97)
Titin, myosin light chains and C-protein in the developing and failing human heart. (1994) (96)
Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. (1996) (96)
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia (2011) (92)
Alcohol and the risk of myocardial infarction (2001) (92)
Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes. (1975) (92)
Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. (2001) (91)
Effects of ribose on exercise-induced ischaemia in stable coronary artery disease (1992) (89)
Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease. (2006) (87)
Positive inotropism of vanadate in cat papillary muscle (1978) (85)
Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. (2000) (84)
Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. II. Effect of cations and nucleotides on rate constants and dissociation constants. (1973) (82)
Characterization of Ax Adenosine Receptors in Atrial and Ventricular Myocardium From Diseased Human Hearts (1989) (82)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text (2007) (82)
Baseline characteristics of patients recruited into the CARE‐HF study (2005) (81)
Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon. (2003) (80)
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS‐II) trial (2010) (80)
Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator–Activated Receptor γ in Cardiac Fibrosis (2008) (78)
Vanadate and its significance in biochemistry and pharmacology. (1984) (77)
Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. (2016) (75)
CT and MR Evaluation of Pericardial Constriction: A New Diagnostic and Therapeutic Concept (1993) (73)
Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure. (2007) (72)
Ouabain-receptor interactions in (Na+ plus K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor. (1974) (71)
Ten‐year observational follow‐up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes (2016) (71)
Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. (2012) (70)
Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. (1992) (69)
Purified cardiac cell membranes with high (Na+ + K+) ATPase activity contain significant NADH-vanadate reductase activity (1979) (68)
Evidences for a Sulfhydryl Group in the ATP‐Binding Site of (Na++ K+)‐Activated ATPase (1975) (67)
Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension (2012) (65)
Effects of exercise on myocardial adenylate cyclase and Gi alpha expression in senescence. (1993) (65)
Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. (1997) (65)
Cardiac adenylyl cyclase, beta-adrenergic receptors, and G proteins in salt-sensitive hypertension. (1993) (62)
Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. (1999) (61)
The (Na + + K + )-ATPase activity of guinea pig heart muscle in potassium deficiency. (1971) (60)
Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. (1994) (60)
Prognostic impact of NT‐proBNP and renal function in comparison to contemporary multi‐marker risk scores in heart failure patients (2008) (60)
Improvement of cholera toxin-catalyzed ADP-ribosylation by endogenous ADP-ribosylation factor from bovine brain provides evidence for an unchanged amount of Gs alpha in failing human myocardium. (1990) (59)
Effectiveness of Cardiac Glycosides in Human Myocardium With and Without “Downregulated” β‐Adrenoceptors (1990) (58)
Observational follow‐up of the PROactive study: a 6‐year update (2014) (58)
Phenotyping of Sleep‐Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry (2017) (56)
Calcium sensitivity and myosin light chain pattern of atrial and ventricular skinned cardiac fibers from patients with various kinds of cardiac disease. (1990) (56)
Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. (1990) (55)
Adaptive servo‐ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE‐HF (2018) (55)
Radiation-induced heart disease: morphology, changes in catecholamine synthesis and content, beta-adrenoceptor density, and hemodynamic function in an experimental model. (1992) (54)
Effects of α- and β-adrenergic agonists, phosphodiesterase inhibitors and adenosine on isolated human heart muscle preparations (1987) (54)
Role of altered G-protein expression in the regulation of myocardial adenylate cyclase activity and force of contraction in spontaneous hypertensive cardiomyopathy in rats (1992) (52)
Influence of Cardiac Glycosides on their Receptor (1981) (50)
Reduced positive inotropic effects in diseased human ventricular myocardium. (1986) (50)
Isolated Presynaptic Inotropic β‐Adrenergic Supersensitivity of the Transplanted Denervated Human Heart In Vivo (1992) (49)
Evidence against spare or uncoupled β-adrenoceptors in the human heart* (1990) (49)
Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux. (1980) (49)
Different cardiodepressant potency of various calcium antagonists in human myocardium. (1990) (48)
Reduced Effects of Dopexamine on Force of Contraction in the Failing Human Heart Despite Preserved β2-Adrenoceptor Subpopulation (1989) (48)
Effect of smoking on MAP kinase-induced modulation of IL‐8 in human alveolar macrophages (2004) (46)
Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial. (2016) (45)
Evidence for an Interaction of Halothane with the L-type Ca2+ Channel in Human Myocardium (1993) (45)
Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium. (1991) (44)
Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. (2004) (44)
Different numbers of β-receptors in human lymphocyte subpopulations (1982) (44)
Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension (2009) (44)
Negative Inotropic Properties of Isradipine, Nifedipine, Diltiazem, and Verapamil in Diseased Human Myocardial Tissue (1990) (44)
Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. (2008) (43)
Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes. (2006) (43)
International Comparison of Awareness and Attitudes Towards Coronary Risk Factor Reduction: The HELP Study (1997) (43)
Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. (1995) (43)
Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin–angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20) (2010) (43)
Stimulatory (insulin-mimetic) and inhibitory (ouabain-like) action of vanadate on potassium uptake and cellular sodium and potassium in heart cells in culture. (1982) (43)
Chronic aortic dissection: comparison of MR Imaging and transesophageal echocardiography. (1994) (42)
Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure (1992) (42)
Cardiac Glycosides 1785–1985 (1986) (41)
Stimulatory effect of vanadate on the adenylate cyclase of cardiac tissue. (1979) (41)
Enteroviral Heart Disease: Diagnosis by In Situ Hybridization (1988) (41)
Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium. (1997) (41)
Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure (1995) (41)
Cardiac Norepinephrine, p‐Adrenoceptors, and Giα-Proteins in Prehypertensive and Hypertensive Spontaneously Hypertensive Rats (1994) (40)
Multiplicity of cardiac glycoside receptors in the heart (1985) (40)
Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase. (1983) (39)
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study (2007) (39)
Localization of a "postreceptor" defect in human dilated cardiomyopathy. (1989) (38)
Association of rheumatoid arthritis with ergothioneine levels in red blood cells: a case control study. (2006) (37)
Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholds. (1998) (37)
Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking (2006) (37)
Preparation and culture of embryonic and neonatal heart muscle cells: modification of transport activity. (1989) (37)
Digitalis in heart failure! Still applicable? (2005) (37)
Thiazolidinediones and Cardiovascular Risk — A Question of Balance (2009) (36)
Positive inotropic effects in isolated ventricular myocardium from non‐failing and terminally failing human hearts (1988) (36)
Safety and tolerability of beta-blockers: prejudices and reality (2009) (36)
Ouabain receptor interactions in (Na+ + K+)-ATPase preparations. III. On the stability of the ouabain receptor against physical treatment, hydrolases and SH reagents (1973) (36)
Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction. (1995) (36)
NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope. (2012) (36)
The problem of polypharmacy in heart failure (2006) (35)
Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement (2010) (35)
A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study. (2013) (35)
Heart transplantation: hemodynamics over a five-year period. (1991) (35)
Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha. (1994) (34)
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS‐III (2004) (34)
NT‐pro‐BNP predicts worsening renal function in patients with chronic systolic heart failure (2011) (34)
Effect of bacterial endotoxin LPS on expression of INF-gamma and IL-5 in T-lymphocytes from asthmatics. (2007) (34)
Failure of [32P]ADP-ribosylation by pertussis toxin to determine Gi alpha content in membranes from various human tissues. Improved radioimmunological quantification using the 125I-labelled C-terminal decapeptide of retinal transducin. (1991) (33)
Cardiac glycoside receptors in cultured heart cells--II. Characterization of a high affinity and a low affinity binding site in heart muscle cells from neonatal rats. (1984) (32)
Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension. (2012) (32)
Diabetes and cardiovascular risk markers (2005) (32)
Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease (1988) (31)
Myocardial Giα-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock (1995) (31)
Different β‐adrenoceptor‐effector coupling in human ventricular and atrial myocardium (1991) (31)
Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study (2011) (31)
Impact of Rescue-Thrombolysis during Cardiopulmonary Resuscitation in Patients with Pulmonary Embolism (2009) (31)
Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. A contribution to the problem of nonlinear Scatchard plots. (1976) (30)
Treatment in hypertensive cardiac hypertrophy, I. Neuropeptide Y and beta-adrenoceptors. (1995) (30)
Perturbation of sodium-lithium countertransport in red cells. (1985) (30)
Cardiac glycoside receptors in cultured heart cells--I. Characterization of one single class of high affinity receptors in heart muscle cells from chick embryos. (1984) (30)
Consequences of specific [3H]ouabain binding to guinea pig left atria and cardiac cell membranes. (1983) (30)
Significance of exercise-induced ST-segment elevation and T-wave pseudonormalization for improvement of function in healed Q-wave myocardial infarction. (1998) (29)
Distribution of metabolites between mitochondria and cytosol of cultured fibroblastoid rat heart cells (1979) (29)
ADP binding to (Na++K+)-activated ATPase. (1973) (29)
Screening of positive inotropic agents in isolated cardiac preparations from different sources. (1989) (28)
Intracellular calcium handling in isolated ventricular myocytes from cardiomyopathic hamsters (strain BIO 14.6) with congestive heart failure. (1994) (28)
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography. (1999) (28)
The cardiac glycoside-receptor system in the human heart. (1983) (28)
Stimulatory effect of vanadate on cyclic AMP levels in cat papillary muscle. (1980) (28)
Mortality in a cardiac intensive care unit (2012) (28)
Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation (1979) (27)
Heart failure and electrolyte disturbances. (1992) (27)
Enhanced sensitivity of the failing human myocardium to cardiac glycosides and Na(+)-channel activators. (1996) (27)
Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalaemia. (1977) (27)
Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na+ + K+)-ATPase activity. (1982) (27)
[Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]. (2007) (26)
Exogenous factors influencing the human erythrocyte sodium–lithium countertransport system (1984) (26)
Long-term follow-up of 82 patients with chronic disease of the thoracic aorta using spin-echo and cine gradient magnetic resonance imaging. (2000) (26)
Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium. (1988) (25)
Na+‐Channel Activators Increase Cardiac Glycoside Sensitivity in Failing Human Myocardium (1992) (25)
Pioglitazone and mechanisms of CV protection. (2010) (25)
Specific and unspecific binding of [3H](--)dihydroalprenolol to cardiac tissue. (1979) (25)
Effect of thyroid status on beta-adrenergic receptor, adenylate cyclase activity and guanine, nucleotide regulatory unit in rat cardiac and erythrocyte membranes. (1982) (24)
Safety and tolerability of beta-blockers: prejudices & reality. (2010) (24)
Local Thrombolysis for Successful Treatment of Acute Stroke in an Adolescent with Cardiac Myxoma (2011) (24)
The relationship and prognostic impact of low-T3 syndrome and NT-pro-BNP in cardiovascular patients. (2010) (24)
NT-pro-BNP for differential diagnosis in patients with syncope. (2009) (24)
Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes. (2015) (23)
Contractility of the transplanted, denervated human heart. (1991) (23)
Quantification of Giα-proteins in the failing and nonfailing human myocardium (1992) (23)
Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in vivo. (1994) (23)
Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation. (2008) (22)
Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis (2017) (22)
cAMP‐Dependent Protein Kinase A‐Stimulated Sarcoplasmic Reticulum Function in Heart Failurea (1998) (22)
Concentration-response curves of positive inotropic agents before and after ouabain pretreatment. (1985) (22)
Beta adrenoceptors and m-cholinoceptors in myocardium of hearts with coronary artery disease or idiopathic dilated cardiomyopathy removed at cardiac transplantation. (1990) (22)
Coupling of M-cholinoceptors and A1 adenosine receptors in human myocardium. (1994) (22)
Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study (2011) (22)
Impaired TNFα-induced VEGF Expression in Human Airway Smooth Muscle Cells from Smokers with COPD: Role of MAPkinases and Histone Acetylation—Effect of Dexamethasone (2007) (21)
Study on the differential modifications of (Na+ plus K+)-ATPase and its partial reactions by dimethylsulfoxide. (1974) (20)
Antiadrenergic effect of M-cholinoceptor stimulation on human ventricular contractility in vivo. (1992) (20)
Alterations of the force-frequency relation depending on stages of heart failure in humans. (1994) (20)
MRI in patients with pacemakers: overview and procedural management. (2012) (20)
Treatment in hypertensive cardiac hypertrophy, II. Postreceptor events. (1995) (20)
Correlation of myosin heavy chain expression in the rat with cAMP in different models of hypertension-induced cardiac hypertrophy. (1993) (20)
Predicting the long-term effects of cardiac resynchronisation therapy from baseline variables and the early response. A report from CARE-HF (Cardiac Resynchronisation in Heart Failure) (2006) (19)
Congenitally corrected transposition of the great arteries (L-TGA) with situs inversus totalis in adulthood: findings with magnetic resonance imaging. (2000) (19)
Beta1-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation (2010) (19)
[Guidelines for therapy of chronic heart failure]. (2005) (19)
Cholinergic baroreflex vasodilatation: defect in heart transplant recipients due to denervation of the ventricular baroreceptor. (1992) (19)
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. (2009) (18)
[Guidelines for therapy of chronic heart failure. German Society of Cardiology-Heart and Cardiovascular Research]. (1998) (18)
Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial. (2011) (18)
Na+ Channel Activators as Positive Inotropic Agents for the Treatment of Chronic Heart Failure (2001) (18)
β-Adrenergic receptors in guinea-pig myocardial tissue (1976) (18)
Increased number of cardiac adrenergic receptors following local heart irradiation. (1989) (18)
Thromboembolism in heart failure: who should be treated? (2000) (17)
IL-12-induced T-bet expression and IFNgamma release in lymphocytes from asthmatics--role of MAPkinases ERK-1/-2, p38(MAPK) and effect of dexamethasone. (2007) (17)
Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). (2003) (17)
Magnetic Resonance Imaging of Carcinoid Heart Disease (2009) (16)
Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium. (1996) (16)
Dilated angiopathy: a specific subtype of allograft coronary artery disease. (1991) (16)
Magnesium restores the altered force-frequency relationship in failing human myocardium. (1993) (16)
Continuous central haemodynamic measurements during the six‐minute walk test and daily life in patients with chronic heart failure (2009) (16)
Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry (2014) (16)
Calcium for resuscitation? (1991) (16)
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. (1999) (15)
Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heart (1988) (15)
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective (2009) (15)
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. (1996) (15)
Quantitative correlation of cardiac glycoside binding to its receptor and inhibition of the sodium pump in chicken heart cells in culture. (1983) (15)
Binding of digitalis derivatives to beef, cat and human cardiac (Na+ + K+)-ATPase. Affinity and kinetic constants. (1984) (15)
A young mother with severe chest pain (1998) (14)
Informed Consent Prior to Coronary Angiography in a Real World Scenario: What Do Patients Remember? (2010) (14)
Adenosine receptors in the human heart: Pharmacological characterization in nondiseased and cardiomyopathic tissue (1993) (14)
Progression of coronary and valvular heart disease in patients on dialysis. (1985) (14)
Novel ECG-based scoring tool for prediction of takotsubo syndrome (2018) (14)
Ouabain-receptor interactions in (Na++K+)-ATPase preparations (2004) (14)
Anomalous drainage of the right superior vena cava into the left atrium in a 61-year-old woman. (1998) (14)
The effectiveness of inotropic agents in isolated cardiac preparations from the human heart (1988) (14)
Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study. (2011) (14)
Force-frequency relation in human heart failure. (1992) (14)
Association of serious adverse events with Cheyne–Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE‐Heart Failure substudy analysis (2020) (13)
Cardiac Glycoside Receptors and Positive Inotropy (1984) (13)
Beta-adrenergic receptors and m-cholinergic receptors in human lung. Findings following in vivo and in vitro exposure to the beta-adrenergic receptor agonist, terbutaline. (1991) (13)
cAMP-dependent protein kinase A-stimulated sarcoplasmic reticulum function in heart failure. (1998) (13)
Force-frequency-relation in human atrial and ventricular myocardium (1993) (13)
Extensive hepatic portal venous gas and gastric emphysema after successful resuscitation. (2011) (13)
Evidence for two kinetically and functionally different types of cardiac glycoside receptors in the heart. (1984) (13)
Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium. (1991) (13)
Properties of cardiac alpha- and beta-adrenoceptors in spontaneously hypertensive rats (1988) (13)
The management of heart failure – an overview (2000) (13)
NT-pro-BNP measured at discharge predicts outcome in multimorbid diabetic inpatients with a broad spectrum of cardiovascular disease (2007) (12)
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study (2010) (12)
Studies of the nucleoside transporter inhibitor, draflazine, in the human myocardium (1994) (12)
Evidence against spare or uncoupled beta-adrenoceptors in the human heart. (1990) (12)
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. (1990) (12)
Ouabain binding and inotropy in acute potassium depletion in guinea pigs. (1986) (12)
Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium (1990) (12)
The enhanced contractility in phospholamban deficient mouse hearts is not associated with alterations in Ca2+-sensitivity or myosin ATPase-activity of the contractile proteins (2000) (12)
Inotropic response to DPI 201‐106 in the failing human heart (1989) (12)
Cardiac norepinephrine, beta-adrenoceptors, and Gi alpha-proteins in prehypertensive and hypertensive spontaneously hypertensive rats. (1994) (12)
Effects of Halothane on p‐Adrenoceptors and M‐Cholinoceptors in Human Myocardium: Radioligand Binding and Functional Studies (1993) (12)
Digitalis--friend or foe? (1995) (12)
Reduced Sodium Pump a 1 , a 3 , and b 1-Isoform Protein Levels and Na 1 , K 1-ATPase Activity but Unchanged Na 1-Ca 2 1 Exchanger Protein Levels in Human Heart Failure (1999) (11)
Conservative management of Candida infection of prosthetic aortic graft by means of caspofungin and fluconazole alone. (2011) (11)
Magnetic Resonance Pharmacological Stress for Detecting Coronary Disease Comparison with Echocardiography (2000) (11)
[Lumen enlargement in coronary angioplasty: qualitative and quantitative analysis of vascular mechanisms with intravascular ultrasound]. (1996) (11)
On the action of triamterene on isolated cell membranes. (1976) (11)
Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium. (1992) (11)
Long-term myocardial function after heart transplantation. (1993) (11)
EMD 53998 acts as Ca2+-sensitizer and phosphodiesterase III-inhibitor in human myocardium (1995) (11)
Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study (2010) (10)
Two receptors for cardiac glycosides in the heart. (1984) (10)
[Right heart failure]. (1993) (10)
Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine (2010) (10)
Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection (2010) (10)
Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarction. (2012) (10)
The Safety and Tolerability of Candesartan Cilexetil in CHF (2000) (10)
[Heart tumors--their manifestation through uncharacteristic symptoms]. (1997) (10)
Binding of dihydrodigitoxin to beef and human cardiac (Na+ + K+)-ATPase: evidence for two binding sites in cell membranes. (1983) (10)
Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II) (2011) (10)
Importance of cardiac cell membranes in vanadate-induced NADH oxidation (1981) (10)
Typical and atypical takotsubo-like cardiomyopathy as a manifestation of pheochromocytoma (2008) (10)
«Stunned» und «Hibernating Myocardium»: Diagnostik und klinische Implikationen (1993) (10)
Rationale And Design Of The SERVE HF Study: Treatment Of Sleep-disordered Breathing With Predominant Central Sleep Apnea By Adaptive Servo Ventilation In Patients With Heart Failure (2010) (9)
[The pulmonary artery catheter]. (2009) (9)
Abstract of free communicationsIntracellular actions of APP 201–533, a novel cardiotonic agent: Increase in Ca++sensitivity and economization of the myocardial contractile process (1983) (9)
Positive Inotropic Effects Due to Partial Agonistic Activity of the β‐Adrenoceptor Antagonist Celiprolol Following Amplification of cAMP Formation in Failing Human Myocardium (1992) (9)
Myocardial beta-adrenoceptors and inhibitory G-proteins in myocardial biopsies and in explanted hearts from patients with dilated cardiomyopathy. (1990) (9)
Is the determination of serum digoxin concentration useful for the diagnosis of digitalis toxicity? (1980) (9)
Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial. (2011) (9)
International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. Heart European Leaders Panel. (1997) (9)
Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies (2011) (9)
Comparison of ouabain receptors in sheep myocardium and Purkinje fibres. (1985) (9)
Evidence for negative cooperativity among beta-adrenergic receptors in cardiac and lung tissue of guinea pig. (1979) (9)
h-ANF does not play a role in the regulation of myocardial force of contraction. (1988) (9)
Selective inhibition of the pacemaker channel If improves symptoms in severe dilated cardiomyopathy (2007) (9)
Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium. (1994) (9)
Echinococcus cyst located in the interventricular septum (2006) (9)
Pathophysiology of heart failure (1998) (9)
ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting (2008) (9)
Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase (1993) (8)
Altered inotropism in the failing human myocardium (2004) (8)
Baseline and stimulated ANF plasma levels: is an impaired stimulus-response coupling diagnostically meaningful? (1987) (8)
Lack of sustained hemodynamic effects of the beta 2-adrenoceptor agonist dopexamine in end-stage congestive heart failure. (1990) (8)
Coupling of adenosine receptors to a pertussis toxin-sensitive G protein in the human heart. (1989) (8)
Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardium (2004) (8)
[Iron Deficiency in Chronic Heart Failure: Diagnostic Algorithm and Present-Day Therapeutic Options]. (2017) (8)
The positive inotropic response to milrinone in isolated human and guinea pig myocardium (1986) (8)
An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitus (2008) (8)
Two binding sites for ouabain in cardiac cell membranes. (1984) (8)
Chronic Eosinophilic Pneumonia with Atypical Radiographic Presentation (1998) (8)
[Hemodynamic monitoring in the intensive care unit: pulmonary artery catheter versus PiCCO]. (2011) (8)
Cardiac glycosides 1785 - 1985 : biochemistry - pharmacology - clinical relevance (1986) (8)
Interventional Cardiology and Angiology (1989) (8)
CINACIGUAT, A SOLUBLE GUANYLATE CYCLASE ACTIVATOR, UNLOADS THE HEART IN ACUTE DECOMPENSATED HEART FAILURE (2010) (8)
Increase of Gic. in Human Hearts With Dilated but Not Ischemic Cardiomyopathy (2005) (8)
Changes in beta-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure. (1996) (8)
Expression of,-Arrestins and/3-Adrenergic Receptor Kinases intheFailing HumanHeart (2010) (8)
Comparison of the affinity of human, beef and cat heart (Na+ + K+)-ATPase for different digitalis derivatives. (1984) (8)
Lipid lowering in patients with chronic kidney disease: a SHARP turn in the wrong direction? (2011) (8)
[Interaction between sildenafil and antihypertensive drugs: what is evidence-based?]. (2001) (8)
Myosin P-light chain isoenzymes in the human heart: evidence for diphosphorylation of the atrial P-LC form (1989) (8)
Different negative inotropic activity of Ca2+-antagonists in human myocardial tissue (1990) (7)
Non-Q-wave myocardial infarction: impaired myocardial energy metabolism in regions with reduced 99mTc-MIBI accumulation (2001) (7)
Cardiac glycoside receptors and positive inotropy. Evidence for more than one receptor? (1984) (7)
The inotropic effects of dopamine and its precursor levodopa on isolated human ventricular myocardium (1985) (7)
Different numbers of beta-receptors in human lymphocyte subpopulations. (1982) (7)
[Intracoronary ultrasound changes the therapeutic approach in ambivalent angiography findings]. (1997) (7)
Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE‐HF trial (2020) (7)
Percutaneous transluminal coronary angioplasty of focal coronary lesions after cardiac transplantation (1993) (7)
Chronic exposure to low K+ increases cardiac glycoside receptors in cultured cardiac cells: different responses of cardiac muscle and non muscle cells from chicken embryos. (1984) (7)
1014-98 Ca2+ -Uptake of Sarcoplasmic Reticulum Plays a Functional Role for the Force-Frequency Relationship in Man (1995) (7)
Methods of assessment and clinical relevance of myocardial hibernation and stunning. Assessment of myocardial viability. (1998) (7)
QT dispersion in comparison to Tl-201-SPECT for detection of myocardial ischaemia. (2006) (7)
Increase of the extracellular magnesium concentration reduces cardiac glycoside toxicity in the human myocardium. (1992) (7)
The cardiac glycoside receptor: its properties and its correlation to nucleotide binding sites, phosphointermediate, and (Na++K+)-ATPase activity. (1976) (7)
[The PiCCO catheter]. (2010) (7)
[Adherence to guidelines in CHF therapy in Germany]. (2005) (7)
[Characteristics of patients with coronary ectasias with and without stenotic coronary artery disease]. (2005) (7)
[Current pathophysiologic aspects of heart failure]. (1993) (7)
C-terminal modifications of pertussis toxin-sensitive G-protein alpha-subunits differentially affect immunoreactivity. Evidence against endogenous ADP-ribosylation in human heart, lung, thrombocytes and adipose tissue. (1993) (7)
Magnetic resonance imaging of ductus arteriosus Botalli apertus in adulthood. (1999) (6)
[Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease]. (2008) (6)
2 1 S arcoplasmic reticulum Ca-ATPase modulates cardiac contraction and relaxation * ̈ (2002) (6)
Cardiac glycoside receptor in potassium depletion. (1975) (6)
Influence of digitalis and diuretics on ouabain binding sites on human erythrocytes (1984) (6)
Worldwide spread of lifestyle diseases and its importance for cardiovascular events. (2006) (6)
Ouabain-Sensitive and -Insensitive Cation Transport in in Normotensives and Hypertensives in Hypokalemic States (1984) (6)
Inhibition of human colonic (Na++K+)-ATPase by arachidonic and linoleic acid (1986) (6)
The G protein Gα11 is essential for hypertrophic signalling in diabetic myocardium. (2013) (6)
On the site of action of N,N'-dicyclohexylcarbodiimide as an inhibitor of (Na + + K + )-activated ATPase. (1972) (6)
The effect of positive inotropes on the failing human myocardium. (1997) (6)
[Heart transplantation. Indications--complications--hemodynamic results]. (1986) (6)
Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues. (1993) (6)
Influence of halothane on the effect of cAMP-dependent and cAMP-independent positive inotropic agents in human myocardium. (1994) (6)
Novel ECG-based scoring tool for prediction of takotsubo syndrome (2018) (6)
Comparison of dobutamine-stress magnetic resonance imaging and dipyridamole-Tl-201-SPECT as alternative strategies for the detection of coronary artery disease in patients not suitable for stress-echocardiography (2001) (6)
[Angina pectoris, pathological stress EKG and a normal coronary angiogram]. (1980) (6)
Pioglitazone and bladder cancer – Authors' reply (2011) (6)
[Decompensated aortic valve stenosis--valvuloplasty as an emergency intervention]. (1989) (5)
Reversal of toxic and non-toxic effects of digoxin by digoxin-specific fab fragments in isolated human ventricular myocardium (1987) (5)
Receptor for Cardiac Glycosides (1977) (5)
Fitness for Interrogation and Fitness to Stand Trial (2007) (5)
The value of positive inotropy in acute and chronic heart failure. (1989) (5)
Effect of the Phosphodiesterase Inhibitor UK 61260 on Human Myocardial Inotropy and Diastolic Relaxation (1992) (5)
The effect of xamoterol in failing human myocardium. (1990) (5)
The positive inotropic effects of dopamine and dobutamine in isolated, contracting, diseased human and normal guinea pig ventricular myocardium (1986) (5)
Distribution of cardiac glycosides in heart and brain of dogs and their affinity to the (Na++K+)-ATPase (1979) (5)
Renal function and (NA+ + K+)-ATPase in chronic unilateral hydronephrosis in dogs. (1986) (5)
FORCE-FREQUENCY RELATION IN HUMAN HEART FAILURE. AUTHOR'S REPLY (1992) (5)
Chronic exposure to toxic but not to "therapeutic" concentrations of ouabain increases cardiac glycoside receptors in cardiac muscle cells from chicken embryos. (1984) (5)
[Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis]. (2003) (5)
Diabetes-related defects in sarcoplasmic Ca2+ release are prevented by inactivation of Gα11 and Gαq in murine cardiomyocytes (2010) (5)
Positive inotropic effect of DPI 201-106 in spontaneously hypertensive rats: lack of inhibition by adenosine and cholinergic agents. (1988) (5)
[Myocardial involvement in Fabry's disease (author's transl)]. (2008) (5)
PREVALENCE AND PREDICTORS OF SLEEP-DISORDERED BREATHING IN PATIENTS WITH STABLE CHRONIC HEART FAILURE: FINAL DATA OF THE SCHLAHF REGISTRY (2015) (5)
[Heart failure in dilated cardiomyopathy. A disorder of cellular calcium homeostasis]. (2008) (5)
Additive and non-additive positive inotropic effects in human and guinea-pig myocardium (1986) (4)
β‐Blocking Agents and Positive Inotropic Agents in the Therapy of Chronic Heart Failure (1990) (4)
Na+-Li+ countertransport in human erythrocytes--effects of hypokalaemia, oral contraceptives and antihypertensive medication. (1985) (4)
[The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients]. (2002) (4)
Quantification of Gi alpha-proteins in the failing and nonfailing human myocardium. (1992) (4)
Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial (2019) (4)
[Epileptic seizures: effects on cardiac function]. (2011) (4)
Cardiac glycoside binding sites in cultured heart muscle cells. (1984) (4)
[Peculiarities of cardiac glycoside therapy in the aged]. (1991) (4)
First pass radionuclide scintigraphy for long-term follow-up after heart and heart-lung transplantation. (1987) (4)
Heart rate at discharge in patients with acute decompensated heart failure is a predictor of mortality (2020) (4)
[Alterations of the cAMP-adenylate cyclase system in the failing human heart. Consequences for the therapy with inotropic drugs]. (1990) (4)
[Natriuretic peptides BNP and NT-pro-BNP--the "new troponins" for estimation of heart failure?]. (2003) (4)
Balloon embolization of a pulmonary arteriovenous fistula after cavopulmonary anastomosis in tricuspid atresia. (1988) (4)
Myocardial Gi alpha-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock. (1995) (4)
[Altered calcium homeostasis in chronic heart failure]. (1996) (4)
[Therapy with glitazones--a risk for cardiovascular disease?]. (2007) (4)
[Novel indications for phosphodiesterase type 5 inhibitors]. (2007) (4)
Effects of and 13-adrenergic agonists, phosphodiesterase inhibitors and adenosine on isolated human ( Humans 1 heart muscle v. preparations Animals (1987) (4)
[Thrombosis of the deep leg and pelvic veins in congenital agenesis of the vena cava inferior]. (1999) (4)
[Chylothorax as a postoperative complication of aortocoronary bypass operation]. (1999) (4)
Beta-adrenergic receptors in guinea-pig myocardial tissue. (1976) (4)
Digitalis intoxication and treatment with digoxin antibody fragments in renal failure (1989) (4)
[Dissection of the ramus interventricularis anterior in blunt chest trauma]. (2008) (4)
[Amiodarone-induced thyroid gland dysfunctions]. (2010) (4)
Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial. (2015) (3)
Non-additive positive inotropic effects of amrinone and ouabain on cat papillary muscles (1984) (3)
Additive positive inotropic effects of milrinone, ouabain and calcium in diseased human ventricular myocardium (1986) (3)
Negative inotropic effect of vanadate in ventricular myocardium in the presence of 3-isobutyl-1-methylxanthine or isoprenaline (2004) (3)
[Exenatide--an incretin-mimetic agent for the treatment of type 2 diabetes mellitus]. (2007) (3)
Chairmen's Foreword: beta-blockade across the cardiovascular continuum—when and where to use? (2009) (3)
[Long-term effects of sildenafil in a patient with scleroderma-associated pulmonary hypertension and Raynaud's syndrome]. (2004) (3)
[Clinical value of magnetic resonance tomography in imaging coronary stenoses. A comparison with coronary angiography and myocardial scintigraphy]. (2008) (3)
Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure. (1990) (3)
Response to letter regarding article, "Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized Pilot RenPro-Trial (Renal Protection Trial)". (2013) (3)
The Ageing Heart (1998) (3)
Identification of hemodynamically significant restenosis after percutaneous transluminal coronary angioplasty in acute myocardial infarction by transesophageal dobutamine stress echocardiography and comparison with myocardial single photon emission computed tomography. (2001) (3)
Cardiovascular events in patients with type 2 diabetes (2002) (3)
[Challenge in diabetes therapy: effects of glitazones beyond blood glucose control]. (2009) (3)
The value of diuretics in chronic heart failure demonstrated by an implanted haemodynamic monitor. (2002) (3)
Prevalence and predictors of sleep‐disordered breathing in chronic heart failure: the SchlaHF‐XT registry (2022) (3)
[Critical care medicine: who should really care for the patient?]. (2005) (3)
[Pharmacodynamic aspects of drug interactions--receptor affinity and pharmacologic interactions]. (1979) (3)
Cardiac glycoside tolerance in cultured chicken heart muscle cells — A dose-dependent phenomenon (1985) (3)
[The treatment of aortic isthmus stenosis in adults using balloon dilatation and stent implantation]. (1998) (3)
[End-diastolic volumes of the left ventricle in computer tomography in comparison to heart catheter ventriculography]. (1981) (3)
[Alcohol and myocardial infarct. Epidemiological and experimental studies on the effect of alcohol on vascular relaxation and coronary sclerosis]. (1998) (3)
Significance of thromboembolism in heart failure (2000) (3)
Comment on “Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS‐III, by JGF Cleland and others” (2006) (3)
[Secondary prevention of cardiovascular diseases]. (2004) (3)
[Preoperative cardiovascular risk assessment]. (1991) (3)
Indikationen für die Digitalistherapie (1983) (3)
Digitalis therapy – Relevance of heart rate reduction (1998) (3)
[Elevation of the ST segment and positive troponin T as a sign of myocardial damage in acute stroke]. (2009) (3)
[33-year-old patient with postpartum myocardial infarct]. (1997) (3)
Reproducibility of in‐hospital worsening heart failure event adjudication in the RELAX‐AHF‐EU trial (2019) (3)
[Heart failure with thiazolidinedione treatment: what do we know today?]. (2009) (3)
Chronisches Cor pulmonale (2005) (3)
[Hyperglycemia and cardiovascular events]. (2004) (3)
[Therapy of chronic heart failure with positive inotropic drugs]. (1986) (3)
[Missing medical care?]. (2002) (2)
Effects of Halothane on ??-Adrenoceptors and M-Cholinoceptors in Human Myocardium: Radioligand Binding and Functional Studies (1993) (2)
[Digitalis therapy 1994]. (1994) (2)
A comparison of the effects of ouabain, dihydroouabain and 3 alpha-methyldigitoxigenin glucoside on guinea pig left atria. (1984) (2)
[Amiodarone-induced liver dysfunctions]. (2010) (2)
The ouabain receptor in the myocardium and conduction system of the sheep heart (1986) (2)
Reduced Sodium Pumpa1, a3, and b1-Isoform Protein Levels and Na,K-ATPase Activity but Unchanged Na-Ca Exchanger Protein Levels in Human Heart Failure (1999) (2)
Stimulation of human cardiac adenylate cyclase by vanadate (1980) (2)
[Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance]. (2006) (2)
LATE-BREAKING ABSTRACT: Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results (2015) (2)
[Racing heart and angina pectoris in a 19-year-old male. Possibly the result of cannabis smoking?]. (2004) (2)
Normal and Pathological Anatomy (1998) (2)
Pneumomediastinum and striking family history: uncommon case of Birt-Hogg-Dubé syndrome. (2012) (2)
Regulation of Force of Contraction in the Aged and Diseased Myocardium (1989) (2)
Prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists : results from the DIASPORA study : review (2011) (2)
[Nitric oxide as a signal molecule in the cardiovascular system. Nobel Prize for Medicine in 1998]. (1998) (2)
[Current therapy for unstable angina pectoris]. (1999) (2)
Evidence against a role of (Na++K+-ATPase in the alpha-adrenoceptor mediated positive inotropic effect of phenylephrine (1980) (2)
[Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?]. (2007) (2)
[Etiologic diagnosis and therapy of pericarditis and pericardial effusion]. (1998) (2)
[Coronary Heart Disease: Advances in Diagnostics and Therapy]. (2017) (2)
Rare Cause for Sudden Right Heart Failure (2010) (2)
[Percutaneous transfemoral foreign body removal from the heart or great vessels]. (1988) (2)
[ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease]. (2011) (2)
[Glycoside receptors of the heart]. (1988) (2)
[Heart involvement in blunt thoracic trauma]. (2008) (2)
[Sudden cardiac death in a 43-year-old patient with cardiac arrhythmia of unclear origin]. (1988) (2)
The safety and tolerability of candesartan cilexetil in CHF (2000) (2)
Differential Roles of Cardiomyocyte and Macrophage PPAR γ in Cardiac Fibrosis (2008) (2)
[70-year-old woman with cardiac hypertrophy and severe pulmonary hypertension: pre- or postcapillary?]. (2011) (2)
Positive inotropic stimulation in the normal and insufficient human myocardium (2007) (2)
Angina pectoris-like pain provoked by intravenous infusion of adenosine. (1986) (2)
LATE-BREAKING ABSTRACT: Understanding SERVE-HF: A multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV) (2016) (2)
[A 41 year-old male patient with fever of unknown origin and bacteremia with actinobacillus actinomycetemcomitans]. (2003) (2)
[Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes]. (1978) (2)
Cardiac effects of vanadate (1980) (2)
[Wine consumption and prevention of coronary artery disease]. (2016) (2)
[14-year-old patient with septic fever, rapid decline and gait disorder]. (1984) (2)
[Prognosis and diagnosis of thoracic aorta aneurysms. An analysis of 40 patients; 1: Symptomology, risk factors and prognosis]. (1985) (2)
The Pathophysiological Basis, Clinical Presentation, and Therapy of Chronic Heart Failure (1991) (2)
[QT-dispersion--analysis and prognostic implications]. (2008) (2)
[Safety of β-blockers. Prejudices and reality]. (2012) (1)
[Therapy of heart failure. II. Therapy of chronic heart failure]. (1997) (1)
Human colonic (Na++K+)-ATPase and specific ouabain binding are not influenced by lipoxygenase products or superoxide radicals (1988) (1)
Na+-Li+ countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment (1986) (1)
[Effect of cardiac glycosides on intracellular potassium and sodium concentration of the myocardium in chronic hypokalemia]. (1973) (1)
Multiple forms of the sodium pump with different affinities for digitalis (1986) (1)
[Toxic hydrocarbon pneumonitis in a "fire eater"]. (1995) (1)
Abstract 3950: Adjudication of Serious Heart Failure in Patients with Type 2 Diabetes and Cardiovascular Disease: Results From PROactive (2006) (1)
Beta-blockers improve survival in patients with heart failure regardless of renal function. An analysis of the Cardiac Insufficiency BIsoprolol Study II (CIBIS II) trial. (2009) (1)
[Immediate PTCA in acute myocardial infarct--results and indications]. (1996) (1)
[Properties of the receptor for cardiac glycosides (author's transl)]. (1974) (1)
[The Takotsubo syndrome--a psychosomatic cardiac complication?]. (2007) (1)
[A 45-year-old patient with a progressive, currently therapy-resistant disease of the lung]. (1986) (1)
[Therapy of unstable angina pectoris and acute myocardial infarct]. (1987) (1)
Abstract 3946: Morbidity After Reports of Serious Heart Failure in Type 2 Diabetes Patients With Underlying Cardiovascular Disease: Results From PROactive (2006) (1)
Digitalistherapie im Alter (1990) (1)
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. (2007) (1)
91 Cardiac resynchronisation is effective for patients with mild symptoms of heart failure (2006) (1)
XAMOTEROL AND THE FAILING HEART (1989) (1)
Scientific Contributions j 3-Adrenergic Neuroeffector Mechanisms in Cardiac Hypertrophy of Renin Transgenic Rats (2005) (1)
[What is the use of even lower LDL cholesterol by combination therapy? A critical viewpoint]. (2015) (1)
Effect of some Pteridine compounds on the Na+ + K+)-ATPase and on the cardiac glycoside receptor of human heart). (1978) (1)
Cell membrane receptors for cardiac glycosides in the heart (1977) (1)
Treatment with Diuretics (1998) (1)
[Changes of affinity and capacity of cardiac glycoside receptors]. (1985) (1)
Cardiovascular safety of sildenafil in the treatment of erectile dysfunction (2004) (1)
[Life style and health care costs]. (2004) (1)
Prevalence And Sleep Characteristics Of Sleep-disordered Breathing In German Patients With Chronic Heart Failure (2010) (1)
[World Conference 2008 in Dana Point: important developments in the field of pulmonary hypertension]. (2008) (1)
[Heart failure update 2010 and current ESC guidelines]. (2010) (1)
[Cardiac resynchronization in heart failure]. (2002) (1)
[Determination of cardiac glycoside concentration in the serum]. (1975) (1)
Health economics and quality of life issues in heart failure. Foreword. (1998) (1)
[Contusio cordis--too seldom diagnosed?]. (1997) (1)
[Adrenergic beta receptors and guanine nucleotide binding proteins (G-proteins) of the failing human heart]. (1992) (1)
[68-year-old patient with exercise-induced syncope]. (2010) (1)
Regulation of myosin heavy chain (MHC) gene expression in cardiac hypertrophy: Effects of testosterone and cAMP (1992) (1)
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. (2005) (1)
[Indications for ACE inhibitors in chronic heart failure]. (1994) (1)
Multiple Forms of the Cardiac Glycoside Receptor with Different Affinities for Cardiac Glycosides (1987) (1)
Inhibitory and Stimulatory Effects of Vanadate on Sodium Pump of Cultured Heart Cells from Different Species (1983) (1)
[New aspects of digitalis therapy]. (1983) (1)
Chronic cardiac insufficiency: therapy with beta-adrenergic blockers (1998) (1)
[Aortic isthmus stenoses--dilatation in adulthood. A German cooperative study]. (1988) (1)
[Severe myocardial infarction due to late and very late stent thrombosis after coronary artery stenting with drug-eluting stents]. (2008) (1)
[Natriuretic peptides in the therapy of acute decompensated heart failure]. (2011) (1)
[Cardiology. Lessons of clinical cardiological research]. (1999) (1)
[Peripartal cardiomyopathy--its pathophysiology, diagnosis and current therapy]. (2008) (1)
Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranes (1980) (1)
Comparison of sodium-meglumine ioxaglate and iopromide in coronary angiography. (1989) (1)
Changes in cAMP formation in mononuclear leukocytes of heart and renal transplant recipients (1994) (1)
Effect of adaptive servo ventilation on central sleep apnea and sleep structure in systolic heart failure patients: polysomnography data from the SERVE‐HF major sub study (2022) (1)
[Cardiac effects of antikaliuretic diuretics-clinical and biochemical investigation (author's transl)]. (1977) (1)
Regulation of cardiac glycoside receptors with different affinities for cardiac glycosides in cultured rat heart cells. (1988) (1)
Effect of epinine on tension of human renal arteries (1996) (1)
[Characterization of the strophantin receptor in the cell membranes from heart, kidney and brain]. (1973) (1)
Vergleich von Dobutamin-Stress-Magnetresonanztomo-grophie und Dipyridamol-Tl-201-SPECT als alternative Strategien der KHK-Diagnostik bei Patienten mit unzureichendem Schallfenster inderStress-Echokardio-graphie (2001) (1)
[Mitochondrial calcium channels - a new pharmacological target?]. (2011) (1)
[Arterial line placement]. (2008) (1)
Der Knöchel-Arm-Index (2009) (1)
Alterations of Receptors and of Agonist Effectiveness in Myocardial Failure (1988) (1)
[67-year-old patient with speech disorder and dysphagia]. (2008) (1)
[Primary and secondary chylopericardium]. (1986) (1)
Changes in myocardial contractility during shock. (1988) (1)
[Management of cardiovascular diseases]. (2004) (1)
[Dobutamine-induced changes in the myocardial blood flow in patients with coronary heart diseases. A quantitative analysis using [15O] H2O positron emission tomography]. (2000) (1)
["Saint Anthony's fire:" ergotamine-induced vascular spasms as the cause of acute ischemic syndrome]. (1997) (1)
[Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice]. (2007) (1)
[Imaging in cardiology]. (2007) (1)
[Age-dependent regulation of cardiac glycoside receptors]. (1985) (1)
[Does tolerance develop in cardiac glycoside therapy?]. (2008) (1)
[New aspects of the pathogenesis of heart failure]. (1990) (1)
[Death due to liver hemorrhage after infarct lysis]. (1999) (1)
Sensitivity of the failing and nonfailing human heart to cardiac glycosides (1994) (1)
Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the (cid:147)French paradox(cid:148) (2002) (1)
Case studies: reducing risk in patients with diabetes. (2006) (1)
[Implementation of recommendations for the diagnosis of heart failure]. (2010) (1)
[Politics and medicine in the 21st century--misunderstandings, insolvency or foolishness?]. (2003) (1)
Cardiac Failure Altered Expression of ,-Adrenergic Receptor Kinase and 1-Adrenergic Receptors in the Failing Human Heart (2005) (0)
[Pharmacologic treatment of heart failure in the elderly]. (2013) (0)
[Unclear pulmonary infiltrates with eosinophilia, a problem of differential diagnosis] (2000) (0)
[Hemodynamic effects of the beta blocker nebivolol]. (2003) (0)
[Putative atrial tachycardia]. (2009) (0)
[Responsibility in critical care medicine]. (2005) (0)
Abstract 13048: Vardenafil Improves Clinical Symptoms and Digital Blood Flow in Patients With Primary and Secondary Raynaud Syndrome - Results From a Randomized Controlled Trial (2011) (0)
[Dentogenic foci and non-evidence based restorative methods]. (2003) (0)
[Therapy of heart failure. I. Definition, pathophysiology, therapy of acute heart failure]. (1997) (0)
Schwere Myokardinfarkte aufgrundvon späten und sehr späten Stentthrombosennach Implantation medikamentenbeschichteter Koronarstents (2008) (0)
[Clinical aspects of differential drug therapy of chronic heart failure]. (1992) (0)
[A 21-year-old male with progressive body position-dependent cyanosis following 3 corrective operations in tricuspid valve atresia]. (1989) (0)
[Cell water, cell potassium and sodium of the myocardial and skeletal muscle in chronic potassium deficiency]. (1972) (0)
[Lack of correlation of digitalis poisoning symptoms and serum digoxin level - clinical and experimental findings]. (1977) (0)
[Coronary heart disease and heart valve diseases in patients with terminal kidney insufficiency]. (1987) (0)
[Differential diagnosis of thoracic aortic aneurysm]. (1990) (0)
[Cardiocirculatory failure--new therapeutic possibilities]. (1987) (0)
Increase of Giα expression in human cardiomyopathic left ventricles (1992) (0)
[The current debate on lowering LDL cholesterol with ezetimibe]. (2010) (0)
Mini Review on: Simple, Practical, and Evidence-Based - an Algorithm for The Diagnosis and Treatment of Iron Deficiency (2018) (0)
[Clinical research to improve health care in cardiology]. (2013) (0)
Increase in calcium sensitivity of atrial skinned fibres from patients with dilated cardiomyopathy (1989) (0)
[Takes economy precedence over medical action?]. (2012) (0)
[Quantitative aspects of the specific binding of cardiac glycosides to membrane-bound receptors]. (1978) (0)
[Suspected heart failure: how important is the BNP-testing for the general practitioner?]. (2009) (0)
[49-year-old patient with fever attacks, weight loss, arthralgia and abdominal tumor]. (1991) (0)
Regulation of active cation flux by vanadate in beating rat heart muscle cells in culture (1980) (0)
[Cor bovis and metallic gold in heart failure? A positive list for shamans!]. (2003) (0)
[We need studies with relevant parameters!]. (2008) (0)
Endotheliale Dysfunktion - NO-substitution als therapeutisches prinzip (2003) (0)
No effect of adaptive servo-ventilation (ASV) device used on outcomes in SERVE-HF (2019) (0)
Prevalence And Predictors Of Sleep-Disordered Breathing In Patients With Stable Chronic Heart Failure: The SchlaHF Registry (2012) (0)
Diagnosis and Differential Diagnosis of Heart Failure (1998) (0)
[Prevention of cardiovascular diseases with omega-3 fatty acids and viramins?]. (2005) (0)
[Data without gaps: a genuine contribution to quality assurance in heart surgery]. (1999) (0)
[79-year-old patient with paroxysmal artial fibrillation and syncope]. (2009) (0)
Effect ofInotropic Stimulation on theNegative Force-Frequency Relationship inthe Failing HumanHeart (2011) (0)
Baseline and stimulated ANF plasma levels (1987) (0)
[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?]. (2010) (0)
[Cardiomyopathies - heart failure: new concepts]. (2013) (0)
[Preventive cardiology: from prevention to optimal patient care]. (2009) (0)
[Affinity of g-strophantin for the cardiac glycoside receptor of human myocardial cell membranes]. (1975) (0)
Adenylate Cyclase Regulation and ß-Adrenergic Receptors in Guinea-Pig Myocardial Tissue (1977) (0)
Mechanical Circulatory Support (1998) (0)
Acute Coronary Syndrome, Myocardial Infarction, Heart Failure, and Stable Coronary Artery Disease—Specific Considerations in Diabetes (2016) (0)
[Therapy of heart failure with calcium channel blockers?]. (1995) (0)
[Advances and restraints in cardiology]. (2008) (0)
[Heart failure - a scientific and clinical challenge]. (2011) (0)
Heart failure / cardiomyopathy Cinaciguat , a soluble guanylate cyclase activator , unloads the heart but also causes hypotension in acute decompensated heart failure † (2012) (0)
A Review of Sleep Apnoea and its Treatment in Cardiovascular Disease - An important Intervention in Cardiology? (2012) (0)
[Stable angina pectoris can be treated successfully by drugs alone--pro]. (2007) (0)
roentgenogram ofthemonth Unilateral LungHyperinflation ina Patient WithChronic Cough (2015) (0)
Intensified Lipid-Lowering Therapy in Coronary Heart Disease: Is the Concept of “the Lower the Better” Evidence Based? (2011) (0)
[A 57-year-old patient with refractory hypertension and chest pain]. (1984) (0)
[Cardiology: challenges in practice and clinic]. (2008) (0)
[Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect]. (2007) (0)
[Platelet inhibition with prasugrel]. (2010) (0)
Clinical Course and Symptomatology (1998) (0)
[Cardiology and cardiovascular surgery: agreements and controversies]. (2010) (0)
[Binding of ADP to (Na+ + K+)-activated ATPase]. (1972) (0)
PCV24 THE MAHLER STUDY: DIFFERENCES IN RESOURCE USE FOR THE MANAGEMENT OF CHRONIC HEART FAILURE ACROSS 6 EUROPEAN COUNTRIES (2003) (0)
[Myocardial regeneration after myocardial infarction--the speculation continues]. (2004) (0)
C-terminal modifications of pertussis toxin-sensitive G-protein α-subunits differentially affect immunoreactivity (1993) (0)
[Biochemical principles of the effect of digitalis glycosides]. (1982) (0)
[Do we still need digitalis today?]. (2010) (0)
[Artificial heart valves and intravascular hemolysis]. (1988) (0)
[69-year-old woman with therapy refractory dyspnea and weight gain]. (2014) (0)
[Prognosis and diagnosis of thoracic aortic aneurysm. An analysis of 40 patients. 2: Value of diagnostic procedures]. (1985) (0)
[Long-term prognosis following lung embolism]. (1984) (0)
[Peridural injections during acetylsalicylic acid and clopidogrel therapy?]. (2004) (0)
[Pulmonary hypertension]. (2009) (0)
Predictors of pump failure death in heart failure patients in the CARE-HF study (2007) (0)
P4-97: Crt system implantations in the CARE-HF study (2006) (0)
317 Safe and reliable monitoring of pulmonary artery pressure in heart failure patients by the RemonCHF device (2007) (0)
[The cardiology standard is no flash in the pan. Conversation with Prof. Erland Erdmann, Köln]. (2005) (0)
PROactive: In Prior MI Patients Pioglitazone Lowers Risks (2005) (0)
[Chronic aortic valve insufficiency. The current status of its diagnosis and therapy]. (1995) (0)
[Experimental and clinical findings on treatment of cardiac-glucoside intoxication]. (1976) (0)
Downregulation of B-adrenoceptors and reduced inotropy in longstanding heart disease (1987) (0)
[Increase of the urine-time volume through glucose-insulin in cardiogenic shock]. (1976) (0)
[Cardiology between innovation and budget]. (2007) (0)
[Percutaneous instrumental dilatation of heart valve stenoses and aortic isthmus stenosis]. (1989) (0)
Heterologous desensitization of adenylate cyclase in renal and desoxycorticosterone-induced hypertensive cardiomyopathy (1992) (0)
[Outstanding cardiologic publications in the last 50 years in the DMW]. (2005) (0)
The red blood cell: A model for ouabain receptor regulation in the heart? (1986) (0)
[Electron beam computed tomography (EBCT)--a milestone for the diagnosis of coronary heart disease?]. (2008) (0)
LATE-BREAKING ABSTRACT: Adaptive servo-ventilation (ASV) pressures and cardiovascular (CV) mortality risk in SERVE-HF (2016) (0)
Vanadate Antagonizes Detrimental Effects of Serum Deprivation in Cultured Rat Heart Muscle Cells (1983) (0)
3H-ouabain binding to human mononuclear leucocytes (1985) (0)
[Detached point of a thin lumen thorax drainage tube in the right lung]. (2008) (0)
[Current cardiology]. (2001) (0)
[The indications for surgery in asymptomatic high-grade aortic valve stenosis]. (1994) (0)
[Clinico-pharmacologic aspects of cardioactive drugs]. (1995) (0)
[25 years of progress in cardiology--heart failure: from haemodynamics to neuroendocrinology]. (2008) (0)
[The value of cardiac glycosides in the therapy of chronic heart insufficiency]. (1984) (0)
[Echocardiography in intensive care patients. Indications and value]. (1988) (0)
[Finely adjusted differential therapy succeeds this way! References for dose adjustments in heart failure (interview by Dr. Dirk Einecke)]. (2005) (0)
[Correlation of cardiac glycoside binding to their receptors and inhibition of (Na + K)-active ATPase. Clinical significance and application possibilities]. (1974) (0)
[Cardiovascular pharmacology]. (2020) (0)
[PDE5 inhibitors in the treatment of pulmonary hypertension]. (2010) (0)
[Cardiac risk assessment in surgical medicine]. (1995) (0)
[Early diagnosis--successful treatment]. (2016) (0)
[Acute lung embolism]. (1982) (0)
[The "stunned" and "hibernating myocardium"--diagnosis and clinical implications]. (1993) (0)
World Conference Dana Point, 2008: Important developments in the field of pulmonary hypertension (2008) (0)
Effect of Pimobendan in the Failing Human Myocardium (2005) (0)
The effect of classification of arrhythmic sudden cardiac death on the efficacy of cardiac resynchronization therapy in the CARE-HF study (2006) (0)
Dobutamine: positive inotropy by nonselective adrenoceptor agonism in isolated guinea pig and human myocardium (1987) (0)
AB33-2: Effects of cardiac resynchronization therapy on mode of death in heart failure (the Cardiac Resynchronization - Heart Failure [CARE-HF] trial extension phase) (2006) (0)
[Anticardiolipin antibody level in myocardial infarction]. (1998) (0)
[Affinity of various structured cardiac glycosides, DPH and Ro 2-2985 to the receptor of cardiac glycosides]. (1974) (0)
[Thrombocyte aggregation inhibitor after surgery for an abdominal aortic aneurysm]. (2008) (0)
[Therapy with beta blockers in heart failure. Recent studies of carvedilol]. (1996) (0)
[Prophylaxis of thrombembolic diseases with rivaroxaban]. (2010) (0)
[Conservative therapy of unstable angina pectoris]. (1986) (0)
[How does the PROactive Study change therapy of diabetes?]. (2005) (0)
[New developments in diagnostics and treatment of cardiovascular diseases]. (2012) (0)
Stem cell induced myocardial regeneration after myocardial infarction - a continuous speculation (2004) (0)
Coexistence of central sleep apnea or periodic breathing pattern in patients with congestive heart failure and obstructive sleep apnea (2012) (0)
[Is chelation therapy in coronary heart disease useful?]. (2002) (0)
Principles of Therapy (1998) (0)
[Elevated values of creatine kinase]. (2000) (0)
Sleep-Disordered Breathing In Chronic Heart Failure: Gender-Dependent Characteristics Of 1075 Patients (2011) (0)
Pharmacotherapy for chronic heart failure: whento use which drug and at which dose? (2003) (0)
Therapy with ACE Inhibitors (1998) (0)
[Coronary calcification gains more and more clinical relevance as a prognostic factor for coronary events--contra]. (2007) (0)
[Cardiology -- what is new?]. (2005) (0)
[Percutaneous transvenous mitral valvuloplasty in a pregnant patient. Successful treatment of severe mitral stenosis]. (1999) (0)
[Effects of the RALE study. Hyperkalemia following spironolactone treatment]. (2005) (0)
[Heart Murmurs--what must the family physician know?]. (2007) (0)
The clinical manifestation and relevance of diastolic dysfunction - (2004) (0)
[Imaging procedures in diagnosis of aortic dissection]. (1994) (0)
Review 21 S reticulum Ca -ATPase modulates cardiac contraction and relaxation (2003) (0)
[New aspects for therapy of chronic heart failure with positive inotropic substances]. (1991) (0)
4.3 Vitamine, Antioxidanzien (2006) (0)
[Drug-induced vital disorders]. (1987) (0)
Exchanger in the Human Heart (1996) (0)
[Differentiated Drug Therapy - Especially Important in Old Age]. (2018) (0)
Epidemiological investigations on varroosis in Berlin, with special consideration of the Berlin prevention and treatment programme (1993) (0)
5.4 Thrombozyten-aggregationshemmung (2006) (0)
[Diabetes and heart failure]. (2010) (0)
[Glycoside effect on membrane ATPase of the myocardium in chronic potassium deficiency--measurements of (Na + +K + )-ATPase in the guinea pig ventricle]. (1971) (0)
[The central venous catheter. Approach to the subclavian vein]. (2007) (0)
[Anticoagulation in heart insufficiency]. (2000) (0)
[Laser revascularization--a questionable method without revascularization]. (2000) (0)
Percutaneous balloon valvuloplasty of aortic stenosis in 110 consecutive patients (1989) (0)
[Do the best physicians work only for private patients? No, for bureaucracy!]. (2004) (0)
[The therapy of chronic heart failure with beta-receptor blockers?]. (1990) (0)
[Status of clinical electrophysiology in cardiology]. (2001) (0)
Review for "Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial" (2019) (0)
[Glycoside sensitivity in the chronic potassium deficiency--electrophysiological measurements on the papillary muscles of the heart]. (1970) (0)
[Potential for improvement of medical studies from the retrospective viewpoint of medical specialty examination candidates]. (2006) (0)
The contractile reserve of diseased human myocardium (1988) (0)
[The whole width of cardiology]. (2000) (0)
[Theme emphasis for this issue--cardiology]. (2000) (0)
[Validation of patients' knowledge after informed consent prior to coronary angiography]. (2011) (0)
[Phosphodiesterase-4 inhibitors: a new target in treatment of COPD]. (2011) (0)
[Specific predictors for subsequent interventions after myocardial infarctation]. (2015) (0)
[Tetanic spasms, arterial hypertension and hypokalemia]. (1985) (0)
The MAHLER study: Validation of guidelines for the treatment of congestive heart failure (CHF) in Europe (2003) (0)
Heart Failure Symptoms And Sleep-Disordered Breathing In Patients With Stable Chronic Heart Failure - Insights From The SchlaHF-Registry (2012) (0)
Acute antiiscemic effect of angiotensin converting enzyme inhibition in patients with coronary artery disease (1997) (0)
Therapeutic options in CHF - focus on diuretics : proceedings from the Heart Failure Update symposium held in Venice, Italy 28 June - 1 July 2000 (2001) (0)
Therapy with Other Drugs (1998) (0)
[Interview with Prof. Erland Erdmann, Cologne. Oral antidiabetic with protective effect]. (2006) (0)
[Myocardial function, arterial hypertension and coronary angiopathy after heart transplantation]. (1995) (0)
Therapy with Cardiac Glycosides (1998) (0)
[Upright tilt-table test]. (2009) (0)
[Arrhythmia in a patient without cardiac disease]. (2008) (0)
[Evidence based medicine using heart failure as a paradigm]. (1999) (0)
[Significance of serum digoxin concentration and its influencing factors]. (1976) (0)
[Beta-blockers and heart failure--a critical view]. (1996) (0)
[Subclinical thrombosis is a possible risk factor for apoplexy]. (2015) (0)
[Clinical interactions of the heart, cardiovascular system and kidney]. (1989) (0)
[Innovations in cardiology - outstanding perspectives for the coming decade]. (2011) (0)
ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator. (2022) (0)
[18-year-old anemic patient with chronic abdominal pain, weight loss and amenorrhea]. (1990) (0)
AbstractMonday AM, April 24Assessment of myocardial viability by low-dose dobutamine-MRI: Comparison to FDG-PET (1995) (0)
Alternativen zur Herzglykosidtherapie (1983) (0)
[Chronic heart failure: quo vadis?]. (2009) (0)
[Chlamydia pneumoniae--a pathogen with cardiovascular significance]. (1999) (0)
[Cardiac failure]. (2013) (0)
[Heart failure in an elderly patient: always follow the guidelines for treatment?]. (2009) (0)
Aspects of Altered Gene Expression in Heart Failure and Myocardial Hypertrophy (1998) (0)
[The effect of potassium on ouabain-binding to human cardiac cell membranes (author's transl)]. (1976) (0)
[Molecular biology in cardiology. Changes in the phenotype in heart failure and myocardial hypertrophy]. (1994) (0)
[Pericardial valves--excellent hemodynamics, poor long-term results]. (1988) (0)
Gender-dependent characteristics of sleep-disordered breathing in chronic heart failure (2011) (0)
[The boundaries between ambulatory and inpatient medicine from the viewpoint of cardiology, nephrology and pneumology]. (1994) (0)
[Positive inotropic substances--therapeutic perspectives]. (1991) (0)
Review: Statin plus thiazolidinedione use in patients with diabetes at high cardiovascular risk (2007) (0)
[Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances]. (1977) (0)
The abdominal paracentesis (2007) (0)
[Differential therapy with beta blockers. What is their value, what are the risks?]. (2001) (0)
Attenuation of cardiac glycoside effects during long-term treatment (1986) (0)
[Value of polymerase chain reaction (PCR) in diagnosis of tuberculosis and mycobacterium infections caused by ubiquitous mycobacteria]. (1997) (0)
[Preoperative risk estimation and drug therapy in chronic heart insufficiency]. (1991) (0)
Haemodynamic evaluation of the Hancock bovine pericardial heart valve. (1986) (0)
Kardiologie: Innovative Medizin von molekularer Diagnostik bis moderne interventionelle Technologie (2014) (0)
[Meningococcal sepsis in 3 young men]. (1999) (0)
[74 year-old man with dyspnea and edema of the lower legs. Restrictive pericarditis]. (2011) (0)
AB43-1: Patients with New York Heart Association class I/II heart failure also benefit from cardiac resynchronisation therapy (2006) (0)
[Progress in cardiovascular therapy - surgery or intervention?]. (2015) (0)
[Iron deficiency in heart failure. A new diagnostic therapy algorithm - evidence-tested and workable]. (2018) (0)
[Life-threatening interaction between azathioprine and allopurinol]. (1985) (0)
[The electrical cardioversion]. (2007) (0)
[Endoluminal irradiation of coronary arteries: economic aspects before clinical safety?]. (2001) (0)
Success rate safety of CRT devices implantation : Results from the CARE-HF trial (2007) (0)
Health economics and quality of life issues in heart failure : proceedings of a satellite symposium held at the XIXth congress of the European Society of Cardiology, Stockholm, Sweden, 24 August 1997 (1998) (0)
[Consensus conference "Therapy of chronic heart insufficiency" inaugurated by the Munich Collegium for Therapy Research e.V. together with the German Society for Cardiovascular Research]. (1993) (0)
[Design of clinical studies: new approaches beyond randomised investigations]. (2014) (0)
The Benefits of Angiotensin Receptor Blockers in Patients with Chronic Heart Failure and Multiple Co-morbidities (2005) (0)
[Telemonitoring in heart failure: a necessary standard--contra]. (2009) (0)
[Significance of percutaneous coronary interventions. Results of COURAGE and ICTUS follow-up]. (2007) (0)
[A 47-year-old cachectic patient with a deglutition disorder and fever]. (1985) (0)
[Beta blockers in chronic heart failure. Clinical position on the topic]. (1996) (0)
[Interventional cardiology--quo vadis?]. (2010) (0)
[Drug receptor interactions exemplified on cardiac glycoside receptors of the erythrocyte membrane]. (1976) (0)
[Cardiology 2008]. (2008) (0)
[Digitalis therapy in the aged]. (1990) (0)
[Anticoagulation in atrial fibrillation]. (2000) (0)
[Benefits and risks of nitrate preparations in the treatment of angina pectoris]. (2005) (0)
[Heart arrhythmias in advanced age]. (1991) (0)
[Heart failure]. (1991) (0)
The β2-Adrenoceptor Subpopulation and Its Contribution to Force Generation in Human Ventricular Myocardium (1989) (0)
Studies ofthenucleoside transporter inhibitor, draflazine, inthe humanmyocardium (1994) (0)
[Response to the letter by K. Kochsiek, Würzburg]. (1994) (0)
[What does individualized medicine mean today?]. (2013) (0)
Association between symptomatic improvements and outcome: responder analysis of SERVE-HF (2019) (0)
[Studies about the effects of positive inotropic and vasoactive substances] (1993) (0)
[Cardiovascular disease in the elderly]. (2005) (0)
Unilateral lung hyperinflation in a patient with chronic cough. (1997) (0)
[Guideline based diagnosis and therapy can improve medical standards]. (2010) (0)
[Hypo- and hyperkalemias: causes, symptoms, treatment]. (1986) (0)
[Ankle-brachial index]. (2009) (0)
Characteristics of ambulatory daytime, nighttime and resting right ventricular pressures in chronic heart failure patients with implantable hemodynamic monitors (1999) (0)
[Quantitative aspects of specific binding of cardiac glycosides to membrane receptors]. (1979) (0)
[Coronary bypass surgery in obese patients?]. (2001) (0)
Effects of Specific 3-H-Ouabain Binding to the Cardiac Glycoside Receptor on (Na + +K + )-ATPase Activity and on Force of Contraction in Rat Heart (1978) (0)
[Assessment of coronary calcification is important--contra]. (2003) (0)
Review for "Renal outcomes and all‐cause death associated with SGLT ‐2 inhibitor versus other glucose‐lowering drugs ( CVD‐REAL 3 Korea)" (2020) (0)
Failure of [ 32 PJADP-ribosylation by pertussis toxin to determine Gia content in membranes from various human tissues Improved radioimmunological quantification using the 1251-labelied C-terminal decapeptide of retinal (2005) (0)
Is cardiac resynchronisation therapy effective in patients with less severe symptoms (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Erland Erdmann?

Erland Erdmann is affiliated with the following schools:

Erland Erdmann's Academic­Influence.com Rankings

Why Is Erland Erdmann Influential?

Erland Erdmann's Published Works

Published Works

What Schools Are Affiliated With Erland Erdmann?

Erland Erdmann's AcademicInfluence.com Rankings